Keywords: |
cancer chemotherapy; antibiotic therapy; clinical trial; neutropenia; antineoplastic agents; letter; nephrotoxicity; fever; escherichia coli; ciprofloxacin; medical oncology; gentamicin; antibiotic sensitivity; tobramycin; oral drug administration; ototoxicity; gram-negative bacteria; gram-negative bacterial infections; pseudomonas aeruginosa; cephalosporin derivative; timentin; klebsiella; ceftazidime; aminoglycoside antibiotic agent; imipenem; drug resistance, microbial; amikacin; gram negative infection; gram negative bacterium; clavulanic acid; drug mixture; human; priority journal; beta lactam antibiotic; aztreonam; ticarcillin; antibiotics, aminoglycoside; antibiotics, combined
|